CAN Stock Overview
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Cann Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.18 |
| 52 Week High | AU$0.43 |
| 52 Week Low | AU$0.18 |
| Beta | 1.12 |
| 1 Month Change | -12.20% |
| 3 Month Change | -21.74% |
| 1 Year Change | -33.33% |
| 3 Year Change | -84.35% |
| 5 Year Change | -94.58% |
| Change since IPO | -72.09% |
Recent News & Updates
Recent updates
Shareholders May Be A Bit More Conservative With Cann Group Limited's (ASX:CAN) CEO Compensation For Now
Nov 03
Here's Why We're Not Too Worried About Cann Group's (ASX:CAN) Cash Burn Situation
Feb 23What Type Of Returns Would Cann Group's(ASX:CAN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Nov 25
One Forecaster Is Now More Bearish On Cann Group Limited (ASX:CAN) Than They Used To Be
Nov 25Shareholder Returns
| CAN | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | -5.3% | -1.6% | 0.4% |
| 1Y | -33.3% | -31.0% | 0.4% |
Return vs Industry: CAN underperformed the Australian Pharmaceuticals industry which returned -31% over the past year.
Return vs Market: CAN underperformed the Australian Market which returned 0.4% over the past year.
Price Volatility
| CAN volatility | |
|---|---|
| CAN Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in AU Market | 15.5% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: CAN is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CAN's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Peter Koetsier | https://www.canngrouplimited.com |
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Cann Group Limited Fundamentals Summary
| CAN fundamental statistics | |
|---|---|
| Market Cap | AU$71.88m |
| Earnings (TTM) | -AU$26.47m |
| Revenue (TTM) | AU$11.24m |
6.2x
P/S Ratio-2.6x
P/E RatioIs CAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CAN income statement (TTM) | |
|---|---|
| Revenue | AU$11.24m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$11.24m |
| Other Expenses | AU$37.71m |
| Earnings | -AU$26.47m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.068 |
| Gross Margin | 100.00% |
| Net Profit Margin | -235.52% |
| Debt/Equity Ratio | 55.2% |
How did CAN perform over the long term?
See historical performance and comparison